Dynamic epidemiology of group A streptococcal serotypes [2]

Lancet

Volumn 359, Issue 9309, 2002, Pages 889-

  Dale, James B ^a   Shulman, Stanford T ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HYALURONIC ACID; M PROTEIN; MEMBRANE PROTEIN; STREPTOCOCCUS VACCINE;

ANTIGEN SPECIFICITY; DRUG MECHANISM; EPIDEMIC; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOSURVEILLANCE; LETTER; PHARYNGITIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC FEVER; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VIRUS STRAIN;

EID: 0037045874     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07928-X     Document Type: Letter

References (5)

1. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis
2. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments
3. Immunogenicity of a 26-valent group A streptococcal vaccine
4. US nationwide streptococcal pharyngitis serotype surveillance
5. Active bacterial core surveillance of the emerging infections program network